Human Hypoimmune Primary Pancreatic Islets Avoid Rejection and Autoimmunity and Alleviate Diabetes in Allogeneic Humanized Mice

Researchers reported the editing of primary human islet cells to the hypoimmune HLA class I– and class II–negative and CD47-overexpressing phenotype, and their reaggregation into human HIP pseudoislets.